TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL SYNTHETIC BIOLOGY MARKET, BY TOOL
6.1. Overview
6.2. Oligonucleotides and Synthetic DNA
6.3. Enzymes
6.4. Cloning Technologies Kits
6.5. Synthetic Cells
6.6. Chassis Organisms
6.7. Xeno-nucleic Acids
7. GLOBAL SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES
7.1. Overview
7.2. Gene Synthesis
7.3. Genome Engineering
7.4. Sequencing
7.5. Bioinformatics
7.6. Site-directed Mutagenesis
7.7. Cloning
7.8. Measurement and Modeling
7.9. Microfluidics
7.10. Nanotechnology
8. GLOBAL SYNTHETIC BIOLOGY MARKET, BY APPLICATION
8.1. Overview
8.2. Medical Application
8.3. Artifical Tissue and Tissue Regeneration
8.4. Industrial Applications
8.5. Food & Agriculture
8.6. Environmental Applications
9. GLOBAL SYNTHETIC BIOLOGY MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Synthetic biology Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Synthetic biology Market,
10.7. Key developments and Growth Strategies
10.7.1. New Tool Launch/Technologies Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Bota Biosciences Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Tools Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Codexis, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Tools Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Creative Novozymese
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Tools Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. CREATIVE ENZYMES
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Tools Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Enbiotix, Inc
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Tools Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. ILLUMINA, INC.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Tools Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Merck Kgaa (Sigma-Aldrich Co. LLC)
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Tools Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. New England Biolabs
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Tools Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Euro fins Scientific
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Tools Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Novozymes
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Tools Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Pareto Bio, Inc.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Tools Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Scarab Genomics, LLC
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Tools Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Synthego
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Tools Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Synthetic Genomics Inc.
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Tools Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
11.15. Thermo Fisher Scientific, Inc.
11.15.1. Company Overview
11.15.2. Financial Overview
11.15.3. Tools Offered
11.15.4. Key Developments
11.15.5. SWOT Analysis
11.15.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL SYNTHETIC BIOLOGY MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL SYNTHETIC BIOLOGY MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 10 U.S. SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 11 U.S. SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 12 U.S. SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 CANADA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 14 CANADA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 15 CANADA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 16 EUROPE SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 17 EUROPE SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 18 EUROPE SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 EUROPE SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 20 GERMANY SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 21 GERMANY SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 22 GERMANY SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 FRANCE SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 24 FRANCE SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 25 FRANCE SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 26 ITALY SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 27 ITALY SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 28 ITALY SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 SPAIN SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 30 SPAIN SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 31 SPAIN SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 U.K SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 33 U.K SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 34 U.K SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 36 REST OF EUROPE SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 37 REST OF EUROPE SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 38 ASIA PACIFIC SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 39 ASIA PACIFIC SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 40 ASIA PACIFIC SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 41 ASIA PACIFIC SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 42 JAPAN SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 43 JAPAN SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 44 JAPAN SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 45 CHINA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 46 CHINA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 47 CHINA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 INDIA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 49 INDIA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 50 INDIA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 AUSTRALIA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 52 AUSTRALIA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 53 AUSTRALIA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 54 SOUTH KOREA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 55 SOUTH KOREA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 56 SOUTH KOREA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 57 REST OF ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 58 REST OF ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 59 REST OF ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 60 REST OF WORLD SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 61 REST OF WORLD SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 62 REST OF WORLD SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 63 REST OF WORLD SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 64 MIDDLE EAST SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 65 MIDDLE EAST SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 66 MIDDLE EAST SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 67 AFRICA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 68 AFRICA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 69 AFRICA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 70 LATIN AMERICA SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2032 (USD BILLION)
TABLE 71 LATIN AMERICA SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGIES, 2018-2032 (USD BILLION)
TABLE 72 LATIN AMERICA SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2032 (USD BILLION) 
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SYNTHETIC BIOLOGY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SYNTHETIC BIOLOGY MARKET
FIGURE 4 GLOBAL SYNTHETIC BIOLOGY MARKET, SHARE (%), BY TOOL, 2022
FIGURE 5 GLOBAL SYNTHETIC BIOLOGY MARKET, SHARE (%), BY TECHNOLOGIES, 2022
FIGURE 6 GLOBAL SYNTHETIC BIOLOGY MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL SYNTHETIC BIOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: SYNTHETIC BIOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: SYNTHETIC BIOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: SYNTHETIC BIOLOGY MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL SYNTHETIC BIOLOGY MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 BOTA BIOSCIENCES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BOTA BIOSCIENCES INC.: SWOT ANALYSIS
FIGURE 15 CODEXIS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 CODEXIS, INC.: SWOT ANALYSIS
FIGURE 17 CREATIVE NOVOZYMESE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 CREATIVE NOVOZYMESE: SWOT ANALYSIS
FIGURE 19 CREATIVE ENZYMES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 CREATIVE ENZYMES: SWOT ANALYSIS
FIGURE 21 ENBIOTIX, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 ENBIOTIX, INC.: SWOT ANALYSIS
FIGURE 23 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ILLUMINA, INC.: SWOT ANALYSIS
FIGURE 25 MERCK KGAA (SIGMA-ALDRICH CO. LLC): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 MERCK KGAA (SIGMA-ALDRICH CO. LLC): SWOT ANALYSIS
FIGURE 27 NEW ENGLAND BIOLABS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEW ENGLAND BIOLABS: SWOT ANALYSIS
FIGURE 29 EURO FINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 EURO FINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 31 NOVOZYMES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 NOVOZYMES: SWOT ANALYSIS
FIGURE 33 PARETO BIO, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 PARETO BIO, INC.: SWOT ANALYSIS
FIGURE 35 SCARAB GENOMICS, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 SCARAB GENOMICS, LLC: SWOT ANALYSIS
FIGURE 37 SYNTHEGO: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 SYNTHEGO: SWOT ANALYSIS
FIGURE 39 SYNTHETIC GENOMICS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 SYNTHETIC GENOMICS INC.: SWOT ANALYSIS
FIGURE 41 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
